Nutrition
Volume 26, Issue 1 , Pages 106-111 , January 2010

Endotoxin level in ischemia–reperfusion injury in rats: Effect of glutamine pretreatment on endotoxin levels and gut morphology

  • Arda Demirkan, M.D., Ph.D.

      Affiliations

    • Ankara University Faculty of Medicine, Department of Emergency Medicine, Sıhhiye, Ankara, Turkey
    • ,
  • Berna Savaş, M.D., Ph.D.

      Affiliations

    • Ankara University Faculty of Medicine, Department of Pathology, Sıhhiye, Ankara, Turkey
    • ,
  • Mehmet Melli, M.D., Ph.D.

      Affiliations

    • Ankara University Faculty of Medicine, Department of Pharmacology and Clinical Pharmacology, Sıhhiye, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90-312-310-3010/260; fax: +90-312-309-2156.

Received 14 November 2008 ,Accepted 6 April 2009.

References 

  1. Stechmiller JK, Treloar D, Allen N. Gut dysfunction in critically ill patients: a review of the literature. Am J Crit Care. 1997;6:204–209
  2. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101:478–483
  3. Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol Gastrointest Liver Physiol. 1986;250:G749–G753
  4. Vatistas NJ, Nieto JE, Van Hoogmoed L, Gardner I, Snyder JR. Use of an isolated intestinal circuit to evaluate the effect of ischemia and reperfusion on mucosal permeability of the equine jejunum. Vet Surg. 2003;32:52–61
  5. Langer JC, Sohal SS, Blennerhassett P. Mucosal permeability after subclinical intestinal ischemia–reperfusion injury: an exploration of possible mechanisms. J Pediatr Surg. 1995;30:568–572
  6. Wu GH, Wang H, Zhang YW, Wu ZH, Wu ZG. Glutamine supplemented parenteral nutrition prevents intestinal ischemia–reperfusion injury in rats. World J Gastroenterol. 2004;10:2592–2594
  7. Zhang W, Zhiu W, Zhang J, Li N, Li J. Protective effects of glucagon-like peptide 2 on intestinal ischemia–reperfusion rats. Microsurgery. 2008;28:285–290
  8. Nezu Y, Tagawa M, Sakaue Y, Hara Y, Tsuchida S, Ogawa R. Kinetics of endotoxin concentration and tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 activities in the systemic and portal circulation during small intestinal ischemia and reperfusion in dogs. Am J Vet Res. 2002;63:1680–1686
  9. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg. 1990;125:403–404
  10. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med. 1998;158:444–451
  11. Deitch EA. Bacterial translocation: is it of clinical significance?. Gastroenterology. 1990;98:243–244
  12. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003;3:169–176
  13. Ziegler TR, Smith RJ, Byrne TA. Potential role of glutamine supplementation in nutrition support. Clin Nutr. 1993;12(suppl 1):S82–S90
  14. Wilmore DW. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr. 2001;131(suppl 9):2543S–2549S
  15. Newsholme P. Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?. J Nutr. 2001;131(suppl 9):2515S–2522S
  16. Tazuke Y, Wasa M, Shimizu Y, Wang HS, Okada A. Alanyl-glutamine–supplemented parenteral nutrition prevents intestinal ischemia–reperfusion injury in rats. JPEN. 2003;27:110–115
  17. Ikeda S, Zarzaur BL, Johnson CD, Fukatsu K, Kudsk KA. Total parenteral nutrition supplementation with glutamine improves survival after gut ischemia/reperfusion. JPEN. 2002;26:169–173
  18. de Aguilar-Nascimento JE, Gurgel Marques C, Carvalho Mariano A, Bicudo Salomao A, de Souza Neves J. Benefits of intraluminal injection of glutamine for intestinal mucosa during ischemia–reperfusion. Eur Surg Res. 2003;35:352–356
  19. Hall JC, Dobb G, Hall J, de Sousa R, Brennan L, McCauley R. A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med. 2003;29:1710–1716
  20. Conejero R, Bonet A, Grau T, Esteban A, Mesejo A, Montejo JC, et al. Effect of glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study. Nutrition. 2002;18:716–721
  21. Griffiths RD, Allen KD, Andrews FJ, Jones C. Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition. 2002;18:546–552
  22. Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002;30:2032–2037
  23. Nilsson UA, Lundgren O, Haglind E, Bylund-Fellenius AC. Radical production during in vivo intestinal ischemia and reperfusion in the cat. Am J Physiol Gastrointest Liver Physiol. 1989;257:G409–G414
  24. Schoenberg MH, Beger HG. Oxygen radicals in intestinal ischemia and reperfusion. Chem Biol Interact. 1990;76:141–161
  25. Harward TR, Coe D, Souba WW, Klingman N, Seeger JM. Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J Surg Res. 1994;56:351–355
  26. Clark EC, Patel SD, Chadwick PR, Warhurst G, Curry A, Carlson GL. Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate. Gut. 2003;52:224–230
  27. Kojima M, Iwakiri R, Wu B, Fujise T, Watanabe K, Lin T, et al. Effects of antioxidative agents on apoptosis induced by ischaemia–reperfusion in rat intestinal mucosa. Aliment Pharmacol Ther. 2003;18(suppl 1):139–145
  28. Inada K, Endo S, Takahashi K, Suzuki M, Narita T, Yoshida T, et al. Establishment of a new perchloric acid treatment method to allow determination of the total endotoxin content in human plasma by the limulus test and clinical application. Microbiol Immunol. 1991;35:303–314
  29. Conover WJ. Multiple comparison test. Practical nonparametric statistics. 2nd ed.. New York: John Wiley & Sons; 1980;p. 229–39
  30. Bulkley GB. Free radicals and other reactive oxygen metabolites: clinical relevance and the therapeutic efficacy of antioxidant therapy. Surgery. 1993;113:479–483
  31. Tadros T, Traber DL, Heggers JP, Herndon DN. Effects of interleukin-1alpha administration on intestinal ischemia and reperfusion injury, mucosal permeability, and bacterial translocation in burn and sepsis. Ann Surg. 2003;237:101–109
  32. Chang JX, Chen S, Ma LP, Jiang LY, Chen JW, Chang RM, et al. Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock. World J Gastroenterol. 2005;11:5485–5491
  33. Juel IS, Solligard E, Lyng O, Stromholm T, Tvedt KE, Johnsen H, et al. Intestinal injury after thoracic aortic cross-clamping in the pig. J Surg Res. 2004;117:283–295
  34. Bjorck M, Troeng T, Bergqvist D. Risk factors for intestinal ischaemia after aortoiliac surgery: a combined cohort and case–control study of 2824 operations. Eur J Vasc Endovasc Surg. 1997;13:531–539
  35. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology. 1995;108:1566–1581
  36. Ameno H, Tani T, Hanasawa K, Kodama M. New method for the detection of bacterial translocation using intestinal permeability with polyethylene glycol 4000. Eur Surg Res. 2000;32:23–29
  37. Drewe J, Beglinger C, Fricker G. Effect of ischemia on intestinal permeability of lipopolysaccharides. Eur J Clin Invest. 2001;31:138–144
  38. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia–reperfusion injury. Ann Surg. 1990;212:694–700
  39. Mangino MJ, Anderson CB, Murphy MK, Brunt E, Turk J. Mucosal arachidonate metabolism and intestinal ischemia–reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 1989;257:G299–G307
  40. Medeiros AC, Chacon DA, Sales VSF, Egito EST, Brandao-Neto J, Pinherio LAM, et al. Glucan and glutamine reduce bacterial translocation in rats subjected to intestinal ischemia–reperfusion. J Investig Surg. 2006;19:39–46
  41. Fukatsu K, Ueno C, Hashiguchi Y, Hare E, Kinoshita M, Mochizuki H, et al. Glutamine infusion during ischemia is detrimental in a murine gut ischemia/reperfusion model. JPEN. 2003;27:187–192
  42. Hayashi M, Tomita M. Mechanistic analysis for drug permeation through intestinal membrane. Drug Metab Pharmacokinet. 2007;22:67–77
  43. Nagira M, Tomita M, Mizuno S, Kumata M, Ayabe T, Hayashi M. Ischemia/reperfusion injury in the monolayers of human intestinal epithelial cell line Caco-2 and its recovery by antioxidants. Drug Metab Pharmacokinet. 2006;21:230–237

 This study was supported by a grant from TUBİTAK, the Scientific and Technological Research Council of Turkey (project 105S143 [SBAG-HD-35]).

PII: S0899-9007(09)00175-0

doi: 10.1016/j.nut.2009.04.010

Nutrition
Volume 26, Issue 1 , Pages 106-111 , January 2010

Article Tools

* Image Usage & Resolution